Spots Global Cancer Trial Database for philadelphia chromosome negative chronic myelogenous leukemia
Every month we try and update this database with for philadelphia chromosome negative chronic myelogenous leukemia cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| STI571 in Treating Patients With Accelerated Phase Chronic Myelogenous Leukemia | NCT00006052 | Leukemia | imatinib mesyla... | 18 Years - | Novartis | |
| Chemotherapy, Interferon, and Bone Marrow Transplantation in Treating Patients With Chronic Myelogenous Leukemia | NCT00002771 | Leukemia | recombinant int... busulfan cytarabine hydroxyurea idarubicin allogeneic bone... autologous bone... peripheral bloo... radiation thera... | - | National Cancer Institute (NCI) | |
| STI571 in Treating Patients With Chronic Myelogenous Leukemia That Has Not Responded to Interferon Alfa | NCT00006053 | Leukemia | imatinib mesyla... | 18 Years - | Novartis | |
| Chemotherapy, Interferon, and Bone Marrow Transplantation in Treating Patients With Chronic Myelogenous Leukemia | NCT00002771 | Leukemia | recombinant int... busulfan cytarabine hydroxyurea idarubicin allogeneic bone... autologous bone... peripheral bloo... radiation thera... | - | National Cancer Institute (NCI) | |
| Interferon Alfa in Treating Patients With Newly Diagnosed Chronic Myelogenous Leukemia | NCT00002869 | Leukemia | recombinant int... cytarabine hydroxyurea | - | National Cancer Institute (NCI) | |
| STI571 in Treating Patients With Chronic Myelogenous Leukemia That Has Not Responded to Interferon Alfa | NCT00006053 | Leukemia | imatinib mesyla... | 18 Years - | Novartis | |
| Interferon Alfa Plus Sargramostim in Treating Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia | NCT00003561 | Leukemia | recombinant int... sargramostim | 18 Years - | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| STI571 in Treating Patients With Chronic Myelogenous Leukemia in Blast Crisis | NCT00006475 | Leukemia | imatinib mesyla... | 18 Years - | Novartis | |
| Bone Marrow Transplantation Plus Biological Therapy in Treating Patients With Chronic Myeloid Leukemia | NCT00011934 | Leukemia | recombinant int... sargramostim autologous bone... | 12 Years - 70 Years | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Chemotherapy and Biological Therapy With or Without Bone Marrow or Peripheral Stem Cell Transplant in Treating Patients With Chronic Myelogenous Leukemia | NCT00025402 | Leukemia | filgrastim recombinant int... busulfan cyclophosphamid... cytarabine etoposide hydroxyurea idarubicin allogeneic bone... peripheral bloo... radiation thera... | - | National Cancer Institute (NCI) | |
| Interferon Alfa Plus Sargramostim in Treating Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia | NCT00003561 | Leukemia | recombinant int... sargramostim | 18 Years - | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Sargramostim Following Allogeneic Bone Marrow Transplantation in Treating Patients With Chronic Myelogenous Leukemia | NCT00002778 | Leukemia | sargramostim therapeutic all... allogeneic bone... in vitro-treate... | 18 Years - 65 Years | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Chemotherapy and Peripheral Stem Cell Transplantation Followed by Immunotherapy in Treating Patients With Chronic Myelogenous Leukemia | NCT00003727 | Leukemia | filgrastim recombinant int... sargramostim therapeutic aut... carmustine cyclophosphamid... etoposide gemcitabine hyd... melphalan bone marrow abl... in vitro-treate... | - 120 Years | University of Maryland, Baltimore |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
